Trademarkia Logo

Canada

C$
Trademark Search in Canada
SENSE

View On IC.GC.CA

SENSE
REGISTERED

on 2 Dec 2019

Last Applicant/ Owned by

APHRIA INC.

265 Talbot Street WestLeamington

ONTARIO

CA

N8H4H3

Serial Number

1912952 filed on 1st Aug 2018

Registration Number

TMA1064935 registered on 2th Dec 2019

Registration expiry Date

2th Dec 2029

Correspondent Address

FASKEN MARTINEAU DUMOULIN LLP

333 BAY STREET, SUITE 2400BAY ADELAIDE CENTRE, BOX 20TORONTO

ONTARIO

CA

M5H2T6

SENSE

Trademark usage description

cannabis related products, namely oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing cannabis for medicinal purposes, Read More

Classification Information

Class [005]
Cannabis related products, namely oils, salves, concentrated pastes, tinctures, tablets and capsules, each containing cannabis for medicinal purposes, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils, salves, concentrated pastes, tinctures, tablets and capsules each containing resins and oils derived from cannabis for medicinal purposes, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of cannabis, namely resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; topical skin creams, bar and liquid soaps, bath additives, bath herbs, bath oils, body creams, body oils, face and body lotions, face and body milk, face lotion, and skin care preparations each containing derivatives of cannabis, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; personal sexual lubricants; transdermal patches containing cannabis for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays containing cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis and marijuana for medicinal purposes, for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; cannabis related product, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oils derived from cannabis for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy.

Classification kind code

11

Class [029]
Oils and resins derived from cannabis, for use as comestibles; cannabis related product, namely, oils for use as comestibles; oils derived from cannabis for use as comestibles; food products containing cannabis, cannabis resins and cannabis oils, namely butter.

Classification kind code

11

Class [031]
Live cannabis plants; live marijuana plants; cannabis seeds

Classification kind code

11

Class [034]
Dried marijuana, dried cannabis; derivatives of cannabis, namely resins and oils; cannabis and marijuana for recreational use; smokers' articles, namely, smoking pipes, pouches for use with marijuana and cannabis, lighters for smokers, grinders for use with cannabis and marijuana, oral vaporizers for smokers

Classification kind code

11

Mark Details

Serial Number

1912952

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 190
on 13th Nov 2019		Registration Pending
Submitted for opposition 191
on 13th Nov 2019		Registration Fee Notice Sent
Submitted for opposition 42
on 21st Aug 2019		Advertised
Submitted for opposition 26
on 1st Aug 2019		Approved
Submitted for opposition 27
on 12th Jun 2019		Approval Notice Sent
Submitted for opposition 22
on 6th Dec 2018		Search Recorded
Submitted for opposition 20
on 6th Dec 2018		Examiner's First Report
Submitted for opposition 31
on 3rd Aug 2018		Formalized
Submitted for opposition 1
on 2th Aug 2018		Created
Submitted for opposition 30
on 1st Aug 2018		Filed